AzTrials
AzTrials

CopdNCT02995681

Balance Training for Fall Reduction in COPD

A study testing Balance training and Pulmonary rehab in people with Copd and Fall Patients, run by West Park Healthcare Centre at 10 sites in 4 countries.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

People living with Chronic Obstructive Pulmonary Disease (COPD) have problems with their balance and a high incidence of falls compared to those of a similar age. Pulmonary rehabilitation is recommended for people with COPD, however, these training programs do not typically include balance training or fall prevention… Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Copd, Fall Patients
What is being tested?
Balance training and Pulmonary rehab
Could I receive a placebo?
No, everyone receives an active treatment
How many people
258 participants
Where
10 sitesin 4 countries
Study dates
Jan 2017to Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • a physician diagnosis of COPD based on GOLD criteria; a self-reported decline in balance, a fall within the last two years or a recent near fall; and an ability to provide written informed consent

Who cannot join

  • severe cognitive impairment (dementia, neurological condition) an inability to communicate because of language skills (aphasia, non-English speaking), or evidence of a neurological or musculoskeletal condition that severely limits mobility and postural control (e.g. cerebrovascular accident, Parkinson's Disease, amputation) and may jeopardize their safety or influence their balance.

Trial locations and contacts

10 sites in 4 countries.

10 sites in 4 countries

Canada5 sites
  • G.F. Macdonald Centre for Lung Health

    Edmonton, Alberta, T5K 0L4

  • Ottawa Hospital Rehabilitation Centre

    Ottawa, Ontario, K1H 8M2

  • West Park Healthcare Centre

    Toronto, Ontario, M6M2J5

  • Colchester East Hants Health Authority

    Truro, Nova Scotia, B2N 4Z9

  • St. Paul's Pulmonary Rehab Program

    Vancouver, British Columbia, V6Z 1Y6

Other trials in Canada

Australia3 sites
  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, 2050

  • Alfred Health

    Melbourne, Victoria, 3004

  • Western Health

    Saint Albans, Victoria, 3021

Other trials in Australia

Portugal1 site
  • School of Health Sciences, University of Aveiro

    Aveiro, 3810-193

Other trials in Portugal

United Kingdom1 site
  • James Cook University Hospital

    Middlesbrough, North Yorkshire, TS4 3BW

Other trials in United Kingdom

About this study

Official title: Randomized Controlled Trial of Balance Training for Fall Reduction in Individuals With COPD

People living with Chronic Obstructive Pulmonary Disease (COPD) have problems with their balance and a high incidence of falls compared to those of a similar age. Pulmonary rehabilitation is recommended for people with COPD, however, these training programs do not typically include balance training or fall prevention strategies. In this study, patients with COPD who report problems with their balance or have had a fall in the last two years will be assigned to a treatment group (balance training plus pulmonary rehabilitation) or control group (standard pulmonary rehabilitation). We will record the number of falls using monthly diaries and evaluate patient's balance, strength, confidence and quality of life.

Read the detailed description

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in Canada. In addition to lung impairment, secondary effects of the disease are well established including impairments in muscle function and exercise capacity. However, individuals with COPD also have marked deficits in balance and an increased risk of falls with a 3-5 times higher annual fall rate than those of similar age. The underlying mechanisms remain unclear, but several factors have been implicated including decreased physical activity, muscle weakness, altered trunk mechanics, comorbidities, hypoxemia and proprioceptive deficits. Given this unique impairment profile, tailored approaches to balance training and fall prevention are needed in COPD.

Pulmonary rehabilitation (PR) is an integral therapeutic intervention for individuals with COPD. The program typically consists of supervised exercise, disease-specific education, and psychological and social support. Balance training and fall prevention strategies are not currently included in international guidelines for PR and few programs include any balance assessment. We have previously shown that the exercise component of traditional PR has minimal effect on measures of balance and fall risk. We then conducted an RCT to examine the effects of balance training alongside PR, which specifically addressed the profile of balance deficits we had identified in COPD. Tailored balance training alongside PR results in clinically important improvements in balance performance compared to PR alone. Given these results, we now have the opportunity to build on our existing experience to test the effect of the intervention on falls.

The purpose of this study is to establish the efficacy of a tailored balance exercise program for reducing falls in individuals with COPD enrolled in PR. If participation in tailored balance training decreases falls compared to usual PR, this approach will represent an innovative and potential cost-saving strategy to prevent falls and reduce associated healthcare utilization in COPD. Our results will be relevant for guiding clinical and policy-based decision making, given the large population of individuals with COPD and the potential for severe consequences of falls in this population.

The primary objective of this study is to evaluate the long-term effects of tailored balance exercise on the rate of falls in individuals with COPD enrolled in PR. Secondary objectives are to determine 1) the long-term effects of the program on measures of balance, balance confidence and muscle strength; and 2) the cost-utility of the program.

Conditions
Copd, Fall Patients
Being tested
Balance training, Pulmonary rehab
Keywords
COPD, Falls, Balance training
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Balance trainingOther

    Balance exercises will include: functional lower extremity training, gait training under challenging conditions and training to increase stability during changes in body positions.

  • Pulmonary rehabOther

    Pulmonary rehab includes: supervised exercise (aerobic exercise, resistance exercise) disease-specific education, and psychological and social support.

Study groups in NCT02995681
Study groupRoleWhat they receive
Pulmonary rehab and balance trainingExperimentalThe intervention group will receive standard pulmonary rehab plus additional balance training.
Receives: Other: Balance training; Other: Pulmonary rehab
Pulmonary rehabActive comparatorThe control group will receive pulmonary rehab only and a pulmonary rehab home program (walking and lower extremity resistance exercises) upon discharge from pulmonary. They will also receive the same monthly phone calls and three home visits at three, six and nine months to ensure proper technique and progression.
Receives: Other: Pulmonary rehab

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of falls

    Number of falls will be measured using monthly falls diaries

    Measured: 12 months

Secondary outcomes (5)
  1. Berg Balance Scale

    Clinical measure of balance

    Measured: Baseline (pre pulmonary rehab), 8 weeks (post pulmonary rehab), 12 months

  2. Balance Evaluation Systems Test (BESTest)

    Clinical measure of balance

    Measured: Baseline (pre pulmonary rehab), 8 weeks (post pulmonary rehab), 12 months

  3. Activities Specific Balance Confidence Scale

    Balance confidence questionnaire

    Measured: Baseline (pre pulmonary rehab), 8 weeks (post pulmonary rehab), 12 months

  4. 30 Second Repeated Chair Stand Test

    Functional lower body strength test

    Measured: Baseline (pre pulmonary rehab), 8 weeks (post pulmonary rehab), 12 months

  5. European Quality of Life 5-Dimension Questionnaire (EQ-5D-5L)

    Health status questionnaire

    Measured: Baseline (pre pulmonary rehab), 8 weeks (post pulmonary rehab), 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2016 (estimated)
  2. Study startJan 2017
  3. Primary completionMar 2022
  4. Study completionMar 2022

Why it stopped: COVID-19 pandemic restrictions

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
258 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02995681
Sponsor's protocol ID
16-018-WP
Status last verified
May 2023
First submitted
14 Dec 2016
Last updated
8 May 2023
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Nguyen KT, Brooks D, Macedo LG, Ellerton C, Goldstein RS, Alison J, Dechman G, Harrison S, Holland AE, Lee A, Marques A, Spencer L, Stickland MK, Skinner EH, Haines KJ, Beauchamp MK. Development of a clinical prediction model for falls in individuals with COPD. BMJ Open Respir Res. 2025 Dec 25;12(1):e002556. doi: 10.1136/bmjresp-2024-002556.

    PubMed 41448796
  • Alrabbaie H, Beauchamp M, Ellerton C, Goldstein R, Lee AL, Alison JA, Dechman G, Haines KJ, Harrison SL, Holland AE, Marques A, Spencer L, Stickland MK, Skinner EH, Brooks D. Determinants of balance impairment in individuals with Chronic Obstructive Pulmonary Disease: A secondary analysis of a randomized controlled trial. Respir Med. 2025 Dec;250:108537. doi: 10.1016/j.rmed.2025.108537. Epub 2025 Nov 25.

    PubMed 41308797
  • Hao Q, Brooks D, Ellerton C, Goldstein R, Lee AL, Alison JA, Dechman G, Haines KJ, Harrison SL, Holland AE, Marques A, Spencer L, Stickland MK, Skinner EH, Camp PG, Ma J, Beauchamp MK. Pulmonary rehabilitation with balance training for fall reduction in chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med. 2024 Aug 24;24(1):408. doi: 10.1186/s12890-024-03215-2.

    PubMed 39182033
  • Beauchamp MK, Brooks D, Ellerton C, Lee A, Alison J, Camp PG, Dechman G, Haines K, Harrison SL, Holland AE, Marques A, Moineddin R, Skinner EH, Spencer L, Stickland MK, Xie F, Goldstein RS. Pulmonary Rehabilitation With Balance Training for Fall Reduction in Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2017 Nov 20;6(11):e228. doi: 10.2196/resprot.8178.

    PubMed 29158206

Questions about this trial

What is this clinical trial studying?

A study testing Balance training and Pulmonary rehab in people with Copd and Fall Patients, run by West Park Healthcare Centre at 10 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 8 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in Canada, Australia, Portugal, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: COVID-19 pandemic restrictions). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of falls (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02995681, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in